FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

Basel, Switzerland, April 16, 2015-Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof ® IQ ReSTOR ® ...

For years, patients who underwent cataract surgery had to wear glasses or contact lenses afterwards to see clearly. The newly developed ReSTOR® lens has overcome this problem, allowing patients to see ...

(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

According to our data and model for cataract, bilateral ReSTOR ® (2 × €500) implants were always a cost-saving alternative to monofocal IOL implants when viewed from a societal perspective. Our ...

Please provide your email address to receive an email when new articles are posted on . We now have U.S. Food and Drug Administration approval of six presbyopic IOLs: the Advanced Medical Optics ...

Alcon is introducing multifocal and multifocal toric ultraviolet-absorbing IOLs to the AcrySof portfolio, as well as the AcrySof UV-absorbing monofocal IOL with the UltraSert pre-loaded delivery ...

If you are over the age of 65, Medicare will cover the cost of cataract surgery along with a conventional "monofocal" IOL. Patients electing monofocal IOLs typically have both eyes corrected for clear ...

Here are 17 facts and business and legal issues about premium intraocular lenses, a recent technology that can free many cataract surgery patients from having to wear eyeglasses. 1. In one of the few ...